Citigroup’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$234 Hold
51
﹤0.01% 4721
2025
Q1
$249 Hold
51
﹤0.01% 4619
2024
Q4
$343 Sell
51
-1
-2% -$7 ﹤0.01% 4770
2024
Q3
$401 Sell
52
-969
-95% -$7.47K ﹤0.01% 4663
2024
Q2
$6.13K Sell
1,021
-539
-35% -$3.23K ﹤0.01% 4476
2024
Q1
$14.1K Buy
1,560
+483
+45% +$4.35K ﹤0.01% 4368
2023
Q4
$10.2K Buy
1,077
+980
+1,010% +$9.28K ﹤0.01% 4429
2023
Q3
$1.16K Sell
97
-2,152
-96% -$25.6K ﹤0.01% 4316
2023
Q2
$55.1K Sell
2,249
-17,770
-89% -$435K ﹤0.01% 3918
2023
Q1
$627K Buy
20,019
+4,684
+31% +$147K ﹤0.01% 2370
2022
Q4
$1.08M Sell
15,335
-6,999
-31% -$493K ﹤0.01% 1957
2022
Q3
$1.92M Buy
22,334
+21,805
+4,122% +$1.88M ﹤0.01% 1620
2022
Q2
$44K Sell
529
-1,792
-77% -$149K ﹤0.01% 3909
2022
Q1
$386K Sell
2,321
-4,047
-64% -$673K ﹤0.01% 3011
2021
Q4
$1.07M Buy
6,368
+5,736
+908% +$959K ﹤0.01% 2484
2021
Q3
$55K Buy
632
+165
+35% +$14.4K ﹤0.01% 3944
2021
Q2
$25K Sell
467
-31
-6% -$1.66K ﹤0.01% 4496
2021
Q1
$30K Sell
498
-405
-45% -$24.4K ﹤0.01% 4342
2020
Q4
$47K Buy
903
+548
+154% +$28.5K ﹤0.01% 4133
2020
Q3
$17K Sell
355
-42
-11% -$2.01K ﹤0.01% 4041
2020
Q2
$20K Sell
397
-509
-56% -$25.6K ﹤0.01% 4245
2020
Q1
$39K Buy
906
+592
+189% +$25.5K ﹤0.01% 3970
2019
Q4
$13K Buy
314
+217
+224% +$8.98K ﹤0.01% 4634
2019
Q3
$3K Sell
97
-305
-76% -$9.43K ﹤0.01% 4900
2019
Q2
$31K Buy
402
+56
+16% +$4.32K ﹤0.01% 4384
2019
Q1
$61K Buy
346
+210
+154% +$37K ﹤0.01% 3896
2018
Q4
$32K Sell
136
-8
-6% -$1.88K ﹤0.01% 4175
2018
Q3
$31K Buy
+144
New +$31K ﹤0.01% 4341